Using thyroid hormone in brain‐dead donors to maximize the number of organs available for transplantation
- 16 March 2007
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 21 (3) , 405-409
Abstract
Abstract: The aggressive management of brain‐dead (cadaveric) organ donors has been shown to increase organs available for transplantation. Some centers use hormone therapy with thyroid hormone (T4) in selected donors. The purpose of this study is to evaluate the effects of T4 on organs available for transplantation. A policy of aggressive donor management was adopted at our trauma center in 1998. T4 therapy is reserved for the hemodynamically unstable donors who require significant vasopressor support. The records of patients who successfully donated organs between January 2001 and December 2005 were reviewed. Organ donor demographics and whether T4 was used was examined for each donor. T4 was used in 96 of 123 donors (78%). Compared with donors who did not receive T4, those that did were similar in age (32 ± 14 vs. 38 ± 21, p = 0.148), had more organs donated (3.9 ± 1.7 vs. 3.2 ± 1.7, p = 0.048), and had no differences in brain‐death related complications. Despite the severe hemodynamic instability in the T4 group, the number of organs harvested from this group was significantly more than in patients who did not receive T4. The use of T4 in this group may result in the increased salvage of transplantable organs.Keywords
This publication has 21 references indexed in Scilit:
- Aggressive pharmacologic donor management results in more transplanted organs1Transplantation, 2003
- The Effects of Triiodothyronine on Hemodynamic Status and Cardiac Function in Potential Heart DonorsAnesthesia & Analgesia, 1996
- DONOR THYROID FUNCTION DOES NOT AFFECT OUTCOME IN ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1994
- Triiodothyronine (T3) and Cardiovascular Therapeutics: A ReviewJournal of Cardiac Surgery, 1992
- Thyroid function in brain-dead donorsTransplant International, 1990
- Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgeryEuropean Journal of Cardio-Thoracic Surgery, 1989
- CHANGE FROM AEROBIC TO ANAEROBIC METABOLISM AFTER BRAIN DEATH, AND REVERSAL FOLLOWING TRIIODOTHYRONINE THERAPYTransplantation, 1988
- HEMODYNAMIC AND METABOLIC RESPONSES TO HORMONAL THERAPY IN BRAIN-DEAD POTENTIAL ORGAN DONORSTransplantation, 1987
- SIGNIFICANCE OF THYROID DYSFUNCTION IN HUMAN CARDIAC ALLOGRAFT PROCUREMENTTransplantation, 1987
- Prevention of Myocardial Injury During Brain Death by Total Cardiac Sympathectomy in the Chacma BaboonThe Annals of Thoracic Surgery, 1986